{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T20:52:04Z","timestamp":1786481524081,"version":"build-2736575974"},"reference-count":26,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.jaip.2016.03.004","type":"journal-article","created":{"date-parts":[[2016,4,11]],"date-time":"2016-04-11T23:51:38Z","timestamp":1460418698000},"page":"665-670","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["Diagnostic Utility of Urinary LTE4 in Asthma, Allergic Rhinitis, Chronic Rhinosinusitis, Nasal Polyps, and Aspirin Sensitivity"],"prefix":"10.1016","volume":"4","author":[{"given":"Rohit","family":"Divekar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Hagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Rank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Volcheck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Meeusen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirohito","family":"Kita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Butterfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2016.03.004_bib1","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1164\/rccm.201506-1201ED","article-title":"Chronic rhinosinusitis: more than just \u201casthma of the upper airway\u201d","volume":"192","author":"Borish","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2016.03.004_bib2","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jaip.2015.03.013","article-title":"How patient experiences should change our approach to treating patients with aspirin-exacerbated respiratory disease","volume":"3","author":"Laidlaw","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2016.03.004_bib3","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2500\/aap.2012.33.3541","article-title":"Aspirin-exacerbated respiratory disease: burden of disease","volume":"33","author":"Chang","year":"2012","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaip.2016.03.004_bib4","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jaip.2015.06.018","article-title":"Symptom-based clustering in chronic rhinosinusitis relates to history of aspirin sensitivity and postsurgical outcomes","volume":"3","author":"Divekar","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2016.03.004_bib5","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.jaip.2015.03.001","article-title":"Survey-defined patient experiences with aspirin-exacerbated respiratory disease","volume":"3","author":"Ta","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2016.03.004_bib6","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jaci.2007.06.047","article-title":"An economic analysis of aspirin desensitization in aspirin-exacerbated respiratory disease","volume":"121","author":"Shaker","year":"2008","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.03.004_bib7","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.jaci.2005.08.035","article-title":"Aspirin sensitivity and severity of asthma: evidence for irreversible airway obstruction in patients with severe or difficult-to-treat asthma","volume":"116","author":"Mascia","year":"2005","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.03.004_bib8","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/j.jaci.2011.12.979","article-title":"Asthma outcomes: biomarkers","volume":"129","author":"Szefler","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.03.004_bib9","first-page":"27","article-title":"Conversion of leukotriene D4 to leukotriene E4 by a dipeptidase released from the specific granule of human polymorphonuclear leucocytes","volume":"48","author":"Lee","year":"1983","journal-title":"Immunology"},{"key":"10.1016\/j.jaip.2016.03.004_bib10","doi-asserted-by":"crossref","first-page":"3790","DOI":"10.1182\/blood-2011-10-384826","article-title":"Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytes","volume":"119","author":"Laidlaw","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2016.03.004_bib11","doi-asserted-by":"crossref","first-page":"422","DOI":"10.20452\/pamw.1379","article-title":"Incidence of aspirin hypersensitivity in patients with chronic rhinosinusitis and diagnostic value of urinary leukotriene E4","volume":"122","author":"Celejewska-Wojcik","year":"2012","journal-title":"Pol Arch Med Wewn"},{"key":"10.1016\/j.jaip.2016.03.004_bib12","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1164\/ajrccm\/148.6_Pt_1.1447","article-title":"The pivotal role of 5-lipoxygenase products in the reaction of aspirin-sensitive asthmatics to aspirin","volume":"148","author":"Israel","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.jaip.2016.03.004_bib13","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1111\/j.1365-2222.2011.03839.x","article-title":"Urinary concentrations of 15-epimer of lipoxin A(4) are lower in patients with aspirin-intolerant compared with aspirin-tolerant asthma","volume":"41","author":"Yamaguchi","year":"2011","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2016.03.004_bib14","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0091-6749(95)70263-6","article-title":"Diurnal variation of urinary leukotriene E4 and histamine excretion rates in normal subjects and patients with mild-to-moderate asthma","volume":"96","author":"Asano","year":"1995","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.03.004_bib15","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1398-9995.2009.02206.x","article-title":"Elevated urinary leukotriene E excretion in asthma: a comparison of HPLC-mass spectrometry and ELISA","volume":"65","author":"Sanak","year":"2010","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2016.03.004_bib16","first-page":"20","article-title":"Aspirin induced asthma (AIA) with nasal polyps has the highest basal LTE4 excretion: a study vs AIA without polyps, mild topic asthma, and normal controls","volume":"38","author":"Micheletto","year":"2006","journal-title":"Eur Ann Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.03.004_bib17","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.jaci.2014.02.041","article-title":"Aspirin desensitization in patients with aspirin-induced and aspirin-tolerant asthma: a double-blind study","volume":"134","author":"Swierczynska-Krepa","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.03.004_bib18","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1034\/j.1398-9995.1999.00199.x","article-title":"Early increase in urinary leukotriene E4 (LTE4) is dependent on allergen dose inhaled during bronchial challenge in asthmatic subjects","volume":"54","author":"Bancalari","year":"1999","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2016.03.004_bib19","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1136\/thorax.2003.006825","article-title":"Increase in urinary leukotriene LTE4 levels in acute asthma: correlation with airflow limitation","volume":"59","author":"Green","year":"2004","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2016.03.004_bib20","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1158\/1940-6207.CAPR-09-0005","article-title":"Levels of prostaglandin E metabolite and leukotriene E(4) are increased in the urine of smokers: evidence that celecoxib shunts arachidonic acid into the 5-lipoxygenase pathway","volume":"2","author":"Duffield-Lillico","year":"2009","journal-title":"Cancer Prev Res"},{"key":"10.1016\/j.jaip.2016.03.004_bib21","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0090-6980(98)00027-6","article-title":"Immunoaffinity resin for purification of urinary leukotriene E4","volume":"55","author":"Westcott","year":"1998","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1016\/j.jaip.2016.03.004_bib22","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0895-4356(03)00177-X","article-title":"The diagnostic odds ratio: a single indicator of test performance","volume":"56","author":"Glas","year":"2003","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.jaip.2016.03.004_bib23","doi-asserted-by":"crossref","first-page":"e115216","DOI":"10.1371\/journal.pone.0115216","article-title":"Urinary LTE4 levels as a diagnostic marker for IgE-mediated asthma in preschool children: a birth cohort study","volume":"9","author":"Chiu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jaip.2016.03.004_bib24","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.prostaglandins.2010.03.003","article-title":"Increased leukotriene E4 excretion in systemic mastocytosis","volume":"92","author":"Butterfield","year":"2010","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1016\/j.jaip.2016.03.004_bib25","first-page":"469","article-title":"The measurement of leukotrienes in urine as diagnostic option in systemic mastocytosis","volume":"62","author":"Raithel","year":"2011","journal-title":"J\u00a0Physiol Pharmacol"},{"key":"10.1016\/j.jaip.2016.03.004_bib26","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.jaip.2014.09.009","article-title":"Aspirin or other nonsteroidal inflammatory agent exacerbated asthma","volume":"2","author":"Ledford","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol Pract"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219816300137?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219816300137?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:12:30Z","timestamp":1761973950000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219816300137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S2213219816300137"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2016.03.004","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic Utility of Urinary LTE4 in Asthma, Allergic Rhinitis, Chronic Rhinosinusitis, Nasal Polyps, and Aspirin Sensitivity","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2016.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}